Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Catalyst Pharmaceutical Partners Inc

+ Add to Watchlist

CPRX:US

4.4000 USD 0.1000 2.22%

As of 20:10:00 ET on 04/17/2015.

Snapshot for Catalyst Pharmaceutical Partners Inc (CPRX)

Open: 4.4900 Day's Range: 4.3100 - 4.5150 Volume: 516,063
Previous Close: 4.5000 52wk Range: 1.7000 - 5.1000 1-Yr Rtn: +113.59%

Stock Chart for CPRX

No chart data available.
  • CPRX:US 4.4000
  • 1D
  • 1M
  • 1Y
4.5000
Interactive CPRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CPRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2400
Est. EPS (USD) (12/2015) -0.4000
Est. PEG Ratio -
Market Cap (M USD) 360.07
Shares Outstanding (M) 81.83
30 Day Average Volume 655,937
Price/Book (mrq) 8.6295
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CPRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CPRX

Catalyst Pharmaceutical Partners, Inc. is a pharmaceutical company focused on the development and commercialization of prescription drugs for the treatment of addiction. The Company develops drugs for addictions such as methamphetamine, nicotine, prescription pain medications, alcohol, and marijuana, as well as treatments for related addictive disorders, such as obesity and gambling.

Patrick J McEnanyChairman/President/CEO/Co-FounderSteven R MillerChief Operating Officer
Charles W GorodetzkyChief Medical OfficerDavid D MuthExec VP/Chief Commercial Officer
More Company Profile & Key Executives for CPRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil